Table: Zeria Pharm -Q1 group results

Zeria Pharmaceutical

06/08/2026 08:01

    Aug 6 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             21.45               19.49            95.00    
                 (+10.1 pct)         (-9.2 pct)       (+6.6 pct)  
  Operating          1.95                1.52            13.00    
                 (+28.3 pct)         (-61.4 pct)      (+5.1 pct)  
  Recurring          1.43                1.66            13.00    
                 (-13.8 pct)         (-69.6 pct)      (+17.7 pct) 
  Net              866 mln               1.09            10.00    
                 (-20.6 pct)         (-74.1 pct)      (+18.3 pct) 
  EPS             19.65 yen           24.75 yen       226.86 yen  
  Ann Div                             49.00 yen        50.00 yen  
  -Q2 div                             24.00 yen        25.00 yen  
  -Q4 div                             25.00 yen        25.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T